REGIONAL INTRAARTERIAL INFUSION OF CISPLATIN IN PRIMARY HEPATOCELLULAR-CARCINOMA - A PHASE-II STUDY

被引：0
|
作者：
KAJANTI, M
RISSANEN, P
VIRKKUNEN, P
FRANSSILA, K
MANTYLA, M
机构：
[1] UNIV HELSINKI,CENT HOSP,DIV DIAGNOST RADIOL,SF-00290 HELSINKI 29,FINLAND
[2] UNIV HELSINKI,CENT HOSP,DIV PATHOL,SF-00290 HELSINKI 29,FINLAND
来源：
CANCER | 1986年 / 58卷 / 11期
关键词：
D O I：
10.1002/1097-0142(19861201)58:11<2386::AID-CNCR2820581105>3.0.CO;2-G
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2386 / 2388
页数：3
相关论文
共 50 条
  • [21] A PHASE-II STUDY OF ETOPOSIDE IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA BY THE TOKYO-LIVER-CANCER-CHEMOTHERAPY-STUDY-GROUP
    YOSHINO, M
    OKAZAKI, N
    YOSHIDA, T
    KANDA, Y
    MIKI, M
    ODA, H
    SASAGAWA, Y
    HAYASHI, S
    HASHIMOTO, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1989, 19 (02) : 120 - 122
  • [22] PHASE-II TRIAL OF META-AMSA IN HEPATOCELLULAR-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    LEGHA, S
    SAIKI, J
    EYRE, HJ
    OBRYAN, R
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1651 - 1652
  • [23] A PHASE-II TRIAL OF RECOMBINANT LEUKOCYTE INTERFERON PLUS DOXORUBICIN IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    FEUN, LG
    SAVARAJ, N
    HUNG, SE
    REDDY, R
    JEFFERS, L
    BENEDETTO, P
    LIVINGSTONE, AS
    ARDALAN, B
    LEVI, JU
    PARKER, T
    SCHIFF, ER
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (05): : 393 - 395
  • [24] INTRAARTERIAL INFUSION CHEMOTHERAPY ON UNRESECTABLE HEPATOCELLULAR-CARCINOMA UNDER OCCLUSION OF HEPATIC ARTERIAL FLOW
    UNE, Y
    UCHINO, J
    YASUHARA, M
    MISAWA, K
    KAMIYAMA, T
    SHIMAMURA, T
    SATO, N
    NAKAJIMA, Y
    HATA, Y
    CLINICAL THERAPEUTICS, 1993, 15 (02) : 347 - 354
  • [25] INDUCTION OF REMISSION IN HEPATOCELLULAR-CARCINOMA WITH A NEW THYMIDYLATE SYNTHASE INHIBITOR, CB3717 - A PHASE-II STUDY
    BASSENDINE, MF
    CURTIN, NJ
    LOOSE, H
    HARRIS, AL
    JAMES, OFW
    JOURNAL OF HEPATOLOGY, 1987, 4 (03) : 349 - 356
  • [26] CISPLATIN AND DOXORUBICIN FOR HEPATOCELLULAR-CARCINOMA
    OLWENY, CLM
    JOHNSON, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 143 - 143
  • [27] PHASE-II STUDY OF TRIMETREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEPATOCELLULAR-CARCINOMA - SOUTHWEST-ONCOLOGY-GROUP STUDY 8712
    HARVEY, WH
    FLEMING, TR
    GOODMAN, PJ
    HARVEY, JH
    RIVKIN, SE
    MACDONALD, JS
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) : 45 - 46
  • [28] PHASE-II EVALUATION OF DOXORUBICIN PLUS BLEOMYCIN IN HEPATOCELLULAR-CARCINOMA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    RAVRY, MJR
    OMURA, GA
    BARTOLUCCI, AA
    CANCER TREATMENT REPORTS, 1984, 68 (12): : 1517 - 1518
  • [29] ALLELOTYPE STUDY OF PRIMARY HEPATOCELLULAR-CARCINOMA
    FUJIMORI, M
    TOKINO, T
    HINO, O
    KITAGAWA, T
    IMAMURA, T
    OKAMOTO, E
    MITSUNOBU, M
    ISHIKAWA, T
    NAKAGAMA, H
    HARADA, H
    YAGURA, M
    MATSUBARA, K
    NAKAMURA, Y
    CANCER RESEARCH, 1991, 51 (01) : 89 - 93
  • [30] A PHASE-II STUDY OF CISPLATIN IN PATIENTS WITH BILIARY-TRACT CARCINOMA
    OKADA, S
    ISHII, H
    NOSE, H
    YOSHIMORI, M
    OKUSAKA, T
    AOKI, K
    IWASAKI, M
    FURUSE, J
    YOSHINO, M
    ONCOLOGY, 1994, 51 (06) : 515 - 517
12345